MedTrace Logo

Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis

NCT02227836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2019-04-17

Study results available
· View outcomes & findings →

Summary

This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.

Conditions

  • Eosinophilic Esophagitis

Interventions

DEVICE

Allergy Patch Testing

Sponsors & Collaborators

Principal Investigators

  • Karthik Ravi, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227836 on ClinicalTrials.gov